| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 131 |
| 1 | INFLIXIMAB | 61 |
| 2 | VEDOLIZUMAB | 51 |
| 3 | AZATHIOPRINE | 39 |
| 4 | METHOTREXATE SODIUM | 27 |
| 5 | METHOTREXATE | 26 |
| 6 | PREDNISONE | 21 |
| 7 | ADALIMUMAB-AATY | 18 |
| 8 | ADALIMUMAB-ADAZ | 18 |
| 9 | ADALIMUMAB-FKJP | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LULICONAZOLE | 1 | 0.0057 |
| 1 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 2 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 3 | SORBITOL | 1 | 0.0017 |
| 4 | BODY CLEANSER | 1 | 0.0014 |
| 5 | ZOLBETUXIMAB | 2 | 0.0013 |
| 6 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 7 | TRASTUZUMAB-ANNS | 1 | 0.0007 |
| 8 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 2 | 0.0006 |
| 9 | VEDOLIZUMAB | 51 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 1 | Integrin Receptor Antagonist [EPC] | 51 | 0.0006 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 3 | Purine Antimetabolite [EPC] | 39 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 6 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 7 | Aminosalicylate [EPC] | 18 | 0.0002 |
| 8 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 9 | Interleukin-23 Antagonist [EPC] | 17 | 0.0002 |